English
Insider transactions
EDGARHOMOLOGY MEDICINES, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-17.
- Open-market purchases (code P)
- 4 transactions, 3,750,000 shares
- Sum of shares × price per share: 30,000,000
- Open-market sales (code S)
- 11 transactions, 70,338 shares
- Sum of shares × price per share: 505,079.4973
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–42 of 42
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-06 Filed 2026-10-14 | Kalowski Lee Officer: CFO and President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,301 | 8.3198 | 10,824.0598Derived: shares × price per share. Exact value 10824.0598. | 137,170 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-421834 Read from the filing’s XML Dispute this row |
| 2026-10-06 Filed 2026-10-14 | Morrison Jodie Pope Director · Officer: CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,221 | 8.3198 | 26,798.0758Derived: shares × price per share. Exact value 26798.0758. | 340,038 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-421836 Read from the filing’s XML Dispute this row |
| 2026-10-06 Filed 2026-10-14 | Violette Shelia M. Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 917 | 8.3197 | 7,629.1649Derived: shares × price per share. Exact value 7629.1649. | 126,854 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-421835 Read from the filing’s XML Dispute this row |
| 2026-08-25 Filed 2026-08-27 | Kalowski Lee Officer: CFO and President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,972 | 16.56 | 65,776.32Derived: shares × price per share. Exact value 65776.32. | 138,471 | Direct (D) | No | F1
| Open filing 0001193125-26-371293 Read from the filing’s XML Dispute this row |
| 2026-08-25 Filed 2026-08-27 | Violette Shelia M. Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,798 | 16.56 | 46,334.88Derived: shares × price per share. Exact value 46334.88. | 127,771 | Direct (D) | No | F1
| Open filing 0001193125-26-371291 Read from the filing’s XML Dispute this row |
| 2026-08-25 Filed 2026-08-27 | Morrison Jodie Pope Director · Officer: CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,845 | 16.56 | 163,033.2Derived: shares × price per share. Exact value 163033.20. | 343,259 | Direct (D) | No | F1
| Open filing 0001193125-26-371292 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-20 | Violette Shelia M. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 37,500 | 0 | — | 130,569 | Direct (D) | No | F1
| Open filing 0001193125-26-309331 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-20 | Kalowski Lee Officer: CFO and President | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 53,250 | 0 | — | 142,443 | Direct (D) | No | F1
| Open filing 0001193125-26-309324 Read from the filing’s XML Dispute this row |
| 2026-07-16 Filed 2026-07-20 | Morrison Jodie Pope Director · Officer: CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 132,000 | 0 | — | 353,104 | Direct (D) | No | F1
| Open filing 0001193125-26-309327 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Manke Isaac Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 53,521 | 2.80 | 149,858.8Derived: shares × price per share. Exact value 149858.80. | 53,521 | Direct (D) | No | — | Open filing 0001193125-26-294694 Read from the filing’s XML Dispute this row |
| 2026-06-30 Filed 2026-07-02 | Manke Isaac Director | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 53,521 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 0 | Direct (D) | No | F1
| Open filing 0001193125-26-294694 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | Thistle Mary Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310965 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | TZIANABOS ARTHUR Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310983 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | LAPORTE KATHLEEN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310980 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | Xu Diyong Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2, F3
| Open filing 0001193125-26-310970 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | GRAYZEL DAVID S. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2, F3
| Open filing 0001193125-26-310967 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | Iwicki Mark T Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310978 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | Lundberg Sven Ante Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310982 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-07-21 | Manke Isaac Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 10,826 | 0 | — | 10,826 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-310969 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | Manke Isaac Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272698 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | Thistle Mary Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272690 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | GRAYZEL DAVID S. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-272692 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | TZIANABOS ARTHUR Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272697 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | Iwicki Mark T Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272700 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | Xu Diyong Director · 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-272686 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | LAPORTE KATHLEEN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272701 Read from the filing’s XML Dispute this row |
| 2026-06-12 Filed 2026-06-16 | Lundberg Sven Ante Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,810 | 0 | — | 9,810 | Direct (D) | No | F1
| Open filing 0001193125-26-272684 Read from the filing’s XML Dispute this row |
| 2026-05-28 Filed 2026-06-01 | Xu Diyong Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,250,000 | 8.00 | 10,000,000Derived: shares × price per share. Exact value 10000000.00. | 3,502,987 | Indirect (I) See footnotes | No | F1, F2, F4
| Open filing 0000947871-26-000594 Read from the filing’s XML Dispute this row |
| 2026-05-28 Filed 2026-06-01 | Xu Diyong Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 625,000 | 8.00 | 5,000,000Derived: shares × price per share. Exact value 5000000.00. | 625,000 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000594 Read from the filing’s XML Dispute this row |
| 2026-05-28 Filed 2026-06-01 | ORBIMED ADVISORS LLC Director · 10% ownerOrbiMed Capital GP VII LLC Director · 10% ownerOrbiMed Genesis GP LLC Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,250,000 | 8.00 | 10,000,000Derived: shares × price per share. Exact value 10000000.00. | 3,502,987 | Indirect (I) See footnotes | No | F1, F2, F4
| Open filing 0000947871-26-000593 Read from the filing’s XML Dispute this row |
| 2026-05-28 Filed 2026-06-01 | ORBIMED ADVISORS LLC Director · 10% ownerOrbiMed Capital GP VII LLC Director · 10% ownerOrbiMed Genesis GP LLC Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 625,000 | 8.00 | 5,000,000Derived: shares × price per share. Exact value 5000000.00. | 625,000 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000593 Read from the filing’s XML Dispute this row |
| 2026-02-25 Filed 2026-02-27 | Violette Shelia M. Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 2,815 | 4.5144 | 12,708.036Derived: shares × price per share. Exact value 12708.0360. | 55,569 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-083584 Read from the filing’s XML Dispute this row |
| 2026-02-25 Filed 2026-02-27 | Kalowski Lee Officer: CFO and President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,995 | 4.5144 | 18,035.028Derived: shares × price per share. Exact value 18035.0280. | 35,943 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-083588 Read from the filing’s XML Dispute this row |
| 2026-02-25 Filed 2026-02-27 | Morrison Jodie Pope Director · Officer: CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,896 | 4.5144 | 44,674.5024Derived: shares × price per share. Exact value 44674.5024. | 89,104 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-083585 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-03-20 | Kalowski Lee Officer: CFO and President | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 53,250 | 0 | — | 89,193 | Direct (D) | No | F1
| Open filing 0001193125-26-118052 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-03-20 | Morrison Jodie Pope Director · Officer: CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 132,000 | 0 | — | 221,104 | Direct (D) | No | F1
| Open filing 0001193125-26-118053 Read from the filing’s XML Dispute this row |
| 2026-02-24 Filed 2026-03-20 | Violette Shelia M. Officer: Chief Scientific Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 37,500 | 0 | — | 93,069 | Direct (D) | No | F1
| Open filing 0001193125-26-118054 Read from the filing’s XML Dispute this row |
| 2026-01-15 Filed 2026-01-30 | GRAYZEL DAVID S. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 16,363 | 2.75 | 44,998.25Derived: shares × price per share. Exact value 44998.25. | 16,363 | Direct (D) | No | F1, F2
| Open filing 0001193125-26-032247 Read from the filing’s XML Dispute this row |
| 2026-01-15 Filed 2026-01-30 | Lundberg Sven Ante Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 20,363 | 2.75 | 55,998.25Derived: shares × price per share. Exact value 55998.25. | 20,363 | Direct (D) | No | F1
| Open filing 0001193125-26-032246 Read from the filing’s XML Dispute this row |
| 2026-01-15 Filed 2026-01-30 | LAPORTE KATHLEEN Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,272 | 2.75 | 63,998Derived: shares × price per share. Exact value 63998.00. | 23,272 | Direct (D) | No | F1
| Open filing 0001193125-26-032248 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Morrison Jodie Pope Director · Officer: CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 22,506 | 3.46 | 77,870.76Derived: shares × price per share. Exact value 77870.76. | 99,000 | Direct (D) | No | — | Open filing 0001193125-25-308328 Read from the filing’s XML Dispute this row |
| 2025-12-02 Filed 2025-12-04 | Kalowski Lee Officer: CFO and President | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,072 | 3.4607 | 31,395.4704Derived: shares × price per share. Exact value 31395.4704. | 39,938 | Direct (D) | No | — | Open filing 0001193125-25-308327 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.
Showing 1–50 of 63
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 2,717,106 SH | 22,470,467 dollars | Unchanged Prior quarter: 2,717,106 | Open filing 0001104659-26-125242 Filed 2026-11-10 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 1,062,137 SH | 10,122,166 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,008,451 SH | 8,339,890 dollars | Higher by 489,648 Prior quarter: 518,803 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| AMERICAN CENTURY COMPANIES INC Partly reported under another manager | 652,597 SH | 5,396,977 dollars | Higher by 379,845 Prior quarter: 272,752 | Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row |
| Qube Research Technologies Ltd | 381,469 SH | 3,154,749 dollars | Not in the prior quarter’s filings read | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 368,935 SH | 3,051,093 dollars | Higher by 301,890 Prior quarter: 67,045 | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 340,353 SH | 2,814,719 dollars | Higher by 221,846 Prior quarter: 118,507 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Aberdeen Group plc Partly reported under another manager | 302,500 SH | 2,501,675 dollars | Not in the prior quarter’s filings read | Open filing 0001716774-26-000032 Filed 2026-11-10 Dispute this row |
| Sanofi | 244,083 SH | 2,018,566 dollars | Unchanged Prior quarter: 244,083 | Open filing 0001193125-26-448717 Filed 2026-11-05 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 240,954 SH | 1,993,746 dollars | Higher by 118,264 Prior quarter: 122,690 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 192,095 SH | 1,588,626 dollars | Higher by 168,305 Prior quarter: 23,790 | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| TD ASSET MANAGEMENT INC | 190,332 SH | 1,813,864 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row |
| Walleye Capital LLC | 182,428 SH | 1,508,680 dollars | Not in the prior quarter’s filings read | Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 164,470 SH | 1,360,167 dollars | Higher by 149,462 Prior quarter: 15,008 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| JANE STREET GROUP, LLC Partly reported under another manager | 160,819 SH | 1,329,973 dollars | Lower by 1,928 Prior quarter: 162,747 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 130,341 SH | 1,077,920 dollars | Higher by 64,124 Prior quarter: 66,217 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager | 120,897 SH | 998 dollars | Lower by 97,337 Prior quarter: 218,234 | Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 110,331 SH | 912,438 dollars | Higher by 86,743 Prior quarter: 23,588 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager | 107,804 SH | 891,539 dollars | Not in the prior quarter’s filings read | Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row |
| Nutshell Asset Management Ltd | 98,299 SH | 812,933 dollars | Not in the prior quarter’s filings read | Open filing 0002021442-26-000006 Filed 2026-11-13 Dispute this row |
| FIRST TRUST ADVISORS LP | 89,134 SH | 737,138 dollars | Not in the prior quarter’s filings read | Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 88,114 SH | 728,703 dollars | Higher by 35,900 Prior quarter: 52,214 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager | 75,515 SH | 624,509 dollars | Not in the prior quarter’s filings read | Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 69,800 SH | 577,246 dollars | Lower by 109,800 Prior quarter: 179,600 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 60,630 SH | 501,410 dollars | Higher by 54,174 Prior quarter: 6,456 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| Fisher Asset Management, LLC Partly reported under another manager | 37,261 SH | 308,148 dollars | Not in the prior quarter’s filings read | Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row |
| Stonepine Capital Management, LLC | 31,200 SH | 258,024 dollars | Not in the prior quarter’s filings read | Open filing 0001440771-26-000027 Filed 2026-11-13 Dispute this row |
| Integrated Quantitative Investments LLC | 28,438 SH | 235,182 dollars | Not in the prior quarter’s filings read | Open filing 0001941040-26-000818 Filed 2026-11-13 Dispute this row |
| Affinity Asset Advisors, LLC | 27,777 SH | 229,716 dollars | Unchanged Prior quarter: 27,777 | Open filing 0001011438-26-000687 Filed 2026-11-13 Dispute this row |
| FOX RUN MANAGEMENT, L.L.C. | 22,193 SH | 183,536 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002585 Filed 2026-11-12 Dispute this row |
| LPL Financial LLC | 15,176 SH | 125,506 dollars | Lower by 2,994 Prior quarter: 18,170 | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| Jump Financial, LLC Partly reported under another manager | 13,292 SH | 109,925 dollars | Not in the prior quarter’s filings read | Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 13,093 SH | 108,279 dollars | Not in the prior quarter’s filings read | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| DCF Advisers, LLC | 13,000 SH | 107,510 dollars | Not in the prior quarter’s filings read | Open filing 0001013594-26-001138 Filed 2026-11-04 Dispute this row |
| JANE STREET GROUP, LLC Option: Put Partly reported under another manager | 12,300 SH | 101,721 dollars | Not in the prior quarter’s filings read | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Yorkville Advisors Global, LP | 10,000 SH | 82,700 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-126193 Filed 2026-11-12 Dispute this row |
| Aster Capital Management (DIFC) Ltd Partly reported under another manager | 9,817 SH | 81,187 dollars | Not in the prior quarter’s filings read | Open filing 0002040915-26-000006 Filed 2026-11-12 Dispute this row |
| BOLTON SECURITIES CORPORATION | 8,000 SH | 66,160 dollars | Lower by 2,000 Prior quarter: 10,000 | Open filing 0001457457-26-000016 Filed 2026-11-12 Dispute this row |
| Vanguard Global Advisers, LLC | 7,848 SH | 64,903 dollars | Higher by 3,024 Prior quarter: 4,824 | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 7,841 SH | 64,845 dollars | Not in the prior quarter’s filings read | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
| US BANCORP \DE\ Partly reported under another manager | 6,093 SH | 50,389 dollars | Not in the prior quarter’s filings read | Open filing 0000036104-26-000059 Filed 2026-11-05 Dispute this row |
| FMR LLC Partly reported under another manager | 3,115 SH | 25,761 dollars | Lower by 273 Prior quarter: 3,388 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 2,823 SH | 23,346 dollars | Lower by 65 Prior quarter: 2,888 | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| SIMPLEX TRADING, LLC Option: Put | 1,700 SH | 14,059 dollars | Higher by 1,500 Prior quarter: 200 | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| SIMPLEX TRADING, LLC | 1,582 SH | 13,083 dollars | Not in the prior quarter’s filings read | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| Steward Partners Investment Advisory, LLC | 871 SH | 7,203 dollars | Not in the prior quarter’s filings read | Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row |
| JONES FINANCIAL COMPANIES LLLP Partly reported under another manager | 664 SH | 5,823 dollars | Higher by 164 Prior quarter: 500 | Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row |
| Rockefeller Capital Management L.P. Partly reported under another manager | 577 SH | 4,772 dollars | Unchanged Prior quarter: 577 | Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row |
| Russell Investments Group, Ltd. Partly reported under another manager | 454 SH | 3,755 dollars | Unchanged Prior quarter: 454 | Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 317 SH | 472 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- ORBIMED ADVISORS LLC 4,127,987 SH
- Boxer Capital Management, LLC 3,149,310 SH
- BVF INC/IL 2,350,000 SH
- RA CAPITAL MANAGEMENT, L.P. 2,332,457 SH
- Point72 Asset Management, L.P. 1,173,396 SH
- Opaleye Management Inc. 931,000 SH
- Logos Global Management LP 800,000 SH
- SummitTX Capital, L.P. 733,774 SH
- Ikarian Capital, LLC 430,000 SH
- Woodline Partners LP 286,212 SH
- ACORN CAPITAL ADVISORS, LLC 216,171 SH
- Ikarian Capital, LLC 200,000 SH
- MONIMUS CAPITAL MANAGEMENT, LP 132,036 SH
- BOOTHBAY FUND MANAGEMENT, LLC 130,427 SH
- CITADEL ADVISORS LLC 120,663 SH
- BOOTHBAY FUND MANAGEMENT, LLC 61,300 SH
- Carlyle Group Inc. 60,363 SH
- TWO SIGMA INVESTMENTS, LP 49,582 SH
- Quadrature Capital Ltd 36,396 SH
- Cambridge Investment Research Advisors, Inc. 36,162 SH
- BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,613 SH
- DAFNA Capital Management LLC 32,896 SH
- Knott David M Jr 30,412 SH
- NORTHERN TRUST CORP 23,631 SH
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 23,342 SH
- MANGROVE PARTNERS IM, LLC 22,150 SH
- HRT FINANCIAL LP 15,949 SH
- Balyasny Asset Management L.P. 12,342 SH
- ExodusPoint Capital Management, LP 11,336 SH
- MILLENNIUM MANAGEMENT LLC 10,928 SH
- XTX Topco Ltd 10,874 SH
- Private Wealth Asset Management, LLC 1,700 SH
- Arax Advisory Partners 1,111 SH
- FEDERATED HERMES, INC. 1,050 SH
- KERR FINANCIAL PLANNING Corp 600 SH
- Truvestments Capital LLC 162 SH
- Federation des caisses Desjardins du Quebec 70 SH
- Caitong International Asset Management Co., Ltd 45 SH
- ROYAL BANK OF CANADA 43 SH
- GROUP ONE TRADING LLC 34 SH
- AdvisorNet Financial, Inc 2 SH
- MERCER GLOBAL ADVISORS INC /ADV 2 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. Common Stock, $0.00001 par value | 5.9 | 1,755,116.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLSP, L.P. Common Stock, $0.00001 par value | 5.9 | 1,755,116.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLSP, L.L.C. Common Stock, $0.00001 par value | 5.9 | 1,755,116.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| Frazier Life Sciences XI, L.P. Common Stock, $0.00001 par value | 0.1 | 23,029.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLS XI, L.P. Common Stock, $0.00001 par value | 0.1 | 23,029.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLS XI, L.L.C. Common Stock, $0.00001 par value | 0.1 | 23,029.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| Frazier Life Sciences XII, L.P. Common Stock, $0.00001 par value | 0.4 | 125,039.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLS XII, L.P. Common Stock, $0.00001 par value | 0.4 | 125,039.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| FHMLS XII, L.L.C. Common Stock, $0.00001 par value | 0.4 | 125,039.00 | 10/02/2026 Filed 2026-10-09 | SCHEDULE 13G | Open filing 0001231919-26-001441 Dispute this row |
| Boxer Capital Management, LLC Common Stock, $0.0001 par value per share | 7.9 | 2,357,922.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-116951 Dispute this row |
| Boxer Holdings, LP Common Stock, $0.0001 par value per share | 7.9 | 2,357,922.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-116951 Dispute this row |
| Boxer Holdings GP, LLC Common Stock, $0.0001 par value per share | 7.9 | 2,357,922.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-116951 Dispute this row |
| Aaron Davis Common Stock, $0.0001 par value per share | 7.9 | 2,357,922.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001213900-26-116951 Dispute this row |
| Opaleye Management Inc. Common Stock, par value $0.0001 per share | 3.76 | 1,120,000.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 3 | Open filing 0001493152-26-050448 Dispute this row |
| Opaleye, L.P. Common Stock, par value $0.0001 per share | 3.76 | 1,120,000.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 3 | Open filing 0001493152-26-050448 Dispute this row |
| James Silverman Common Stock, par value $0.0001 per share | 3.76 | 1,120,000.00 | 09/30/2026 Filed 2026-11-06 | SCHEDULE 13G/AAmendment 3 | Open filing 0001493152-26-050448 Dispute this row |
| BANK OF AMERICA CORP /DE/ Common Stock | 7.4 | 2,205,390.00 | 09/30/2026 Filed 2026-10-28 | SCHEDULE 13G | Open filing 0000070858-26-000536 Dispute this row |
| ORBIMED ADVISORS LLC COMMON STOCK | 13.9 | 4,127,987.00 | 07/16/2026 Filed 2026-07-20 | SCHEDULE 13D/AAmendment 4 | Open filing 0000947871-26-000713 Dispute this row |
| ORBIMED CAPITAL GP VII LLC COMMON STOCK | 11.8 | 3,502,987.00 | 07/16/2026 Filed 2026-07-20 | SCHEDULE 13D/AAmendment 4 | Open filing 0000947871-26-000713 Dispute this row |
| OrbiMed Genesis GP LLC COMMON STOCK | 2.1 | 625,000.00 | 07/16/2026 Filed 2026-07-20 | SCHEDULE 13D/AAmendment 4 | Open filing 0000947871-26-000713 Dispute this row |
| Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share | 4.95 | 1,173,396.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005496 Dispute this row |
| Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share | 4.95 | 1,173,396.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005496 Dispute this row |
| Steven A. Cohen Common Stock, par value $0.0001 per share | 4.95 | 1,173,396.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000919574-26-005496 Dispute this row |
| Sirenia Capital Management LP Common Stock, par value $0.0001 per share | 0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-005207 Dispute this row |
| Alex Silverstein Common Stock, par value $0.0001 per share | 0 | 0.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0000919574-26-005207 Dispute this row |
| Opaleye Management Inc. Common Stock, par value $0.0001 per share | 5.49 | 931,000.00 | 06/30/2026 Filed 2026-07-31 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-035622 Dispute this row |
| Opaleye, L.P. Common Stock, par value $0.0001 per share | 5.49 | 931,000.00 | 06/30/2026 Filed 2026-07-31 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-035622 Dispute this row |
| James Silverman Common Stock, par value $0.0001 per share | 5.49 | 931,000.00 | 06/30/2026 Filed 2026-07-31 | SCHEDULE 13G/AAmendment 2 | Open filing 0001493152-26-035622 Dispute this row |
| Boxer Capital Management, LLC Common Stock, $0.0001 par value per share | 13.30 | 3,149,310.00 | 06/30/2026 Filed 2026-07-10 | SCHEDULE 13G | Open filing 0001213900-26-077181 Dispute this row |
| Boxer Holdings, LP Common Stock, $0.0001 par value per share | 13.30 | 3,149,310.00 | 06/30/2026 Filed 2026-07-10 | SCHEDULE 13G | Open filing 0001213900-26-077181 Dispute this row |
| Boxer Holdings GP, LLC Common Stock, $0.0001 par value per share | 13.30 | 3,149,310.00 | 06/30/2026 Filed 2026-07-10 | SCHEDULE 13G | Open filing 0001213900-26-077181 Dispute this row |
| Aaron Davis Common Stock, $0.0001 par value per share | 13.30 | 3,149,310.00 | 06/30/2026 Filed 2026-07-10 | SCHEDULE 13G | Open filing 0001213900-26-077181 Dispute this row |
| The Carlyle Group Inc. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Carlyle Holdings I GP Inc. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Carlyle Holdings I GP Sub L.L.C. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Carlyle Holdings I L.P. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| CG Subsidiary Holdings L.L.C. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| TC Group, L.L.C. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Carlyle Investment Management L.L.C. Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Carlyle Genesis UK LLC Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Abingworth LLP Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| Abingworth Bioventures VII LP Common Stock, par value $0.0001 per share | 4.1 | 691,735.00 | 06/30/2026 Filed 2026-07-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0001493152-26-032227 Dispute this row |
| RA Capital Management, L.P. Common Stock, par value $0.0001 per share | 9.8 | 2,332,457.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0001346824-26-000170 Dispute this row |
| Peter Kolchinsky Common Stock, par value $0.0001 per share | 9.8 | 2,332,457.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0001346824-26-000170 Dispute this row |
| Rajeev Shah Common Stock, par value $0.0001 per share | 9.8 | 2,332,457.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0001346824-26-000170 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, par value $0.0001 per share | 9.8 | 2,332,457.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0001346824-26-000170 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, par value $0.0001 per share | 5.3 | 1,248,973.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0000921895-26-001559 Dispute this row |
| BVF I GP LLC Common Stock, par value $0.0001 per share | 5.3 | 1,248,973.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0000921895-26-001559 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, par value $0.0001 per share | 3.9 | 929,003.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0000921895-26-001559 Dispute this row |
| BVF II GP LLC Common Stock, par value $0.0001 per share | 3.9 | 929,003.00 | 05/28/2026 Filed 2026-06-04 | SCHEDULE 13G | Open filing 0000921895-26-001559 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,119,757 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 42,927 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 254,737 |
Filings made before the SEC required XML are listed, not extracted.